达沙替尼能重塑瘤的微环境,使小细胞肺癌对免疫疗法的敏感
Esther Redin1, Nerea Otegui1, Mirentxu Santos2
1University of Navarra, Pamplona, Spain.
Cancer research
|July 25, 2025
概括
将达沙替尼与免疫检查点阻塞相结合,可以增强小细胞肺癌 (SCLC) 的抗瘤免疫力. 这种结合疗法,涉及达沙替尼 (Dasa) 和免疫检查点阻断 (ITc),通过调节T细胞,抗原呈现细胞和自然杀手细胞,显示出卓越的疗效,CCL5作为潜在的反应生物标志物.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 小细胞肺癌 (SCLC) 需要新的免疫治疗策略.
- 达沙替尼 (Dasa) 是Src家族的激酶抑制剂,已经显示出免疫调节的潜力.
- 免疫检查点阻塞 (ITc) 是一种关键的癌症免疫治疗方法.
研究的目的:
- 研究在SCLC中将达沙替尼与免疫检查点阻塞结合的疗效.
- 阐明组合治疗的抗瘤活性背后的免疫机制.
- 为了确定潜在的生物标志物来预测对SCLC免疫疗法的反应.
主要方法:
- 使用了SCLC小鼠模型和3D共同培养系统.
- 使用达沙替尼,抗PD-1,抗CTLA-4和组合疗法.
- 进行了免疫细胞耗尽研究,流细胞计和基因表达分析.
- 分析患者样本的预后基因特征和细胞因子水平.
主要成果:
- 与单一疗法相比,达沙替尼加组合免疫疗法 (Dasa+ITc) 显示出更高的抗瘤疗效.
- Dasa+ITc治疗增加了CD4+T细胞,CD8+T细胞,NK细胞,M1巨细胞和CD11c+APC的透,同时减少了Tregs和M2巨细胞.
- 确定了NK细胞的CCL5产生及其对Dasa+ITc疗效的必要性;增加的CCL5水平与有利的患者结果相关.
结论:
- 将达沙替尼与免疫检查点阻塞结合起来,是治疗SCLC的一个有前途的策略.
- 组合疗法通过调节多个免疫细胞种群来增强抗SCLC免疫反应.
- CCL5作为一种潜在的生物标志物,用于监测SCLC患者的治疗反应.
更多相关视频
09:15Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
Published on: February 24, 2023
3.5K
10:29Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence
Published on: August 14, 2019
10.7K
相关概念视频
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Tumor Immunotherapy
662
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
662
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
